Immunogenicity of heterologous BNT162b2 booster in fully vaccinated individuals with CoronaVac against SARS-CoV-2 variants Delta and Omicron: the Dominican Republic Experience

Eddy Pérez-Then; Carolina Lucas; Valter Silva Monteiro; Marija Miric; Vivian Brache; Leila Cochon; Chantal B. F. Vogels; Elena De la Cruz; Aidelis Jorge; Margarita De los Santos; Patricia Leon; Mallery I. Breban; Kendall Billig; Inci Yildirim; Claire Pearson; Randy Downing; Emily Gagnon; Anthony Muyombwe; Jafar Razeq; Melissa Campbell; Albert Ko; Saad B. Omer; Nathan D. Grubaugh; Sten H. Vermund; Akiko Iwasaki

doi:10.1101/2021.12.27.21268459

Immunogenicity of heterologous BNT162b2 booster in fully vaccinated individuals with CoronaVac against SARS-CoV-2 variants Delta and Omicron: the Dominican Republic Experience

Eddy Pérez-Then, View ORCID ProfileCarolina Lucas, Valter Silva Monteiro, Marija Miric, Vivian Brache, Leila Cochon, Chantal B. F. Vogels, Elena De la Cruz, Aidelis Jorge, Margarita De los Santos, Patricia Leon, Mallery I. Breban, Kendall Billig, Inci Yildirim, Claire Pearson, Randy Downing, Emily Gagnon, Anthony Muyombwe, Jafar Razeq, Melissa Campbell, View ORCID ProfileAlbert Ko, Saad B. Omer, Nathan D. Grubaugh, Sten H. Vermund, View ORCID ProfileAkiko Iwasaki

doi: https://doi.org/10.1101/2021.12.27.21268459

Now published in Nature Medicine doi: 10.1038/s41591-022-01705-6

Eddy Pérez-Then

1Ministry of Health, Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carolina Lucas

2Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Carolina Lucas
For correspondence: carolina.lucas@yale.edu akiko.iwasaki@yale.edu

Valter Silva Monteiro

2Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marija Miric

3Two Oceans in Health, Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vivian Brache

4Departamento de Investigaciones Biomedicas, Clinica Evangelina Rodriguez, PROFAMILIA. Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leila Cochon

4Departamento de Investigaciones Biomedicas, Clinica Evangelina Rodriguez, PROFAMILIA. Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chantal B. F. Vogels

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elena De la Cruz

4Departamento de Investigaciones Biomedicas, Clinica Evangelina Rodriguez, PROFAMILIA. Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aidelis Jorge

4Departamento de Investigaciones Biomedicas, Clinica Evangelina Rodriguez, PROFAMILIA. Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Margarita De los Santos

4Departamento de Investigaciones Biomedicas, Clinica Evangelina Rodriguez, PROFAMILIA. Santo Domingo, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Patricia Leon

6Laboratorio de Referencia, Dominican Republic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mallery I. Breban

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kendall Billig

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Inci Yildirim

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

7Department of Pediatric, Section of Infectious Diseases and Global Health; Yale University School of Medicine, New Haven, CT, USA

8Yale Institute for Global Health, Yale University, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claire Pearson

9Connecticut State Department of Public Health, Rocky Hill, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Randy Downing

9Connecticut State Department of Public Health, Rocky Hill, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Emily Gagnon

9Connecticut State Department of Public Health, Rocky Hill, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anthony Muyombwe

9Connecticut State Department of Public Health, Rocky Hill, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jafar Razeq

9Connecticut State Department of Public Health, Rocky Hill, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Melissa Campbell

7Department of Pediatric, Section of Infectious Diseases and Global Health; Yale University School of Medicine, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Albert Ko

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

10Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Albert Ko

Saad B. Omer

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

8Yale Institute for Global Health, Yale University, New Haven, CT, USA

10Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nathan D. Grubaugh

5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA

11Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sten H. Vermund

12Yale School of Public Health, New Haven, CT, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Akiko Iwasaki

1Ministry of Health, Santo Domingo, Dominican Republic

13Howard Hughes Medical Institute, Chevy Chase, MD, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Akiko Iwasaki
For correspondence: carolina.lucas@yale.edu akiko.iwasaki@yale.edu

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

PreviousNext

Posted December 29, 2021.

Download PDF

Print/Save Options

Download PDF Full Text & In-line Figures XML

More Info

Author Declarations

Data/Code

Immunogenicity of heterologous BNT162b2 booster in fully vaccinated individuals with CoronaVac against SARS-CoV-2 variants Delta and Omicron: the Dominican Republic Experience

Eddy Pérez-Then, Carolina Lucas, Valter Silva Monteiro, Marija Miric, Vivian Brache, Leila Cochon, Chantal B. F. Vogels, Elena De la Cruz, Aidelis Jorge, Margarita De los Santos, Patricia Leon, Mallery I. Breban, Kendall Billig, Inci Yildirim, Claire Pearson, Randy Downing, Emily Gagnon, Anthony Muyombwe, Jafar Razeq, Melissa Campbell, Albert Ko, Saad B. Omer, Nathan D. Grubaugh, Sten H. Vermund, Akiko Iwasaki

medRxiv 2021.12.27.21268459; doi: https://doi.org/10.1101/2021.12.27.21268459

Now published in Nature Medicine doi: 10.1038/s41591-022-01705-6

Share This Article:

Citation Tools

Get QR code

Tweet Widget

Subject Area

Infectious Diseases (except HIV/AIDS)

Reviews and Context

Comment

TRIP Peer Reviews

Community Reviews

Automated Services

Blogs/Media

Author Videos

Subject Areas

All Articles

Addiction Medicine (418)
Allergy and Immunology (740)
Anesthesia (217)
Cardiovascular Medicine (3175)
Dentistry and Oral Medicine (355)
Dermatology (268)
Emergency Medicine (469)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1129)
Epidemiology (13147)
Forensic Medicine (17)
Gastroenterology (878)
Genetic and Genomic Medicine (4980)
Geriatric Medicine (458)
Health Economics (762)
Health Informatics (3134)
Health Policy (1115)
Health Systems and Quality Improvement (1157)
Hematology (418)
HIV/AIDS (988)
Infectious Diseases (except HIV/AIDS) (14451)
Intensive Care and Critical Care Medicine (897)
Medical Education (462)
Medical Ethics (121)
Nephrology (511)
Neurology (4727)
Nursing (252)
Nutrition (700)
Obstetrics and Gynecology (859)
Occupational and Environmental Health (773)
Oncology (2435)
Ophthalmology (692)
Orthopedics (272)
Otolaryngology (335)
Pain Medicine (315)
Palliative Medicine (88)
Pathology (523)
Pediatrics (1263)
Pharmacology and Therapeutics (535)
Primary Care Research (536)
Psychiatry and Clinical Psychology (4062)
Public and Global Health (7296)
Radiology and Imaging (1635)
Rehabilitation Medicine and Physical Therapy (974)
Respiratory Medicine (953)
Rheumatology (468)
Sexual and Reproductive Health (486)
Sports Medicine (409)
Surgery (527)
Toxicology (66)
Transplantation (226)
Urology (196)

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

Immunogenicity of heterologous BNT162b2 booster in fully vaccinated individuals with CoronaVac against SARS-CoV-2 variants Delta and Omicron: the Dominican Republic Experience

Data Availability

Subject Area

Follow this preprint